Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Smith SD et al. – More patients with TL were characterized as germinal–center B cell–of–origin (92%) than patients with de novo large B–cell lymphoma (71%). Immunohistochemistry did not predict relapse–free or overall survival, and ASCT afforded a high rate of PFS in patients with TL.



Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address